Emerging studies into retatrutide, a dual GIP and GLP-1 compound, are showing significant efficacy for obesity control . Initial human assessments have indicated substantial decreases in overall weight and improvements in associated health indicators , notably for individuals with excess weight. Ongoing research center on evaluating the sustained